Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc. · Financials

Track BMEA — free
$1.74 +0.04 (+2.35%) At close · Sep 11
Market Cap
$126.12M
Shares
72.48M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
-$61.8M +55.4%
FY2025 Net Income FY2019–FY2025
Diluted EPS
-$1.18 +69.2%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$70.37M +41.3%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$1.85M $1.86M $5.64M $8.88M
$40.78M $61.98M $118.09M $102.55M $62.71M $28M $3.67M $1.09M
$15.08M $19.33M $25.99M $23.59M $20.92M $13.67M $1.66M $103K
$58.06M $83.51M $144.07M $126.14M $83.63M $41.67M $5.33M $1.2M
-$58.06M -$83.51M -$144.07M -$126.14M -$83.63M -$41.67M -$5.33M -$1.2M
$0 $0 $0 $0 $0 $0
-$32.54M -$61.8M -$138.43M -$117.26M -$81.83M -$41.57M -$5.32M -$1.2M
-$32.54M -$61.8M -$138.43M -$117.25M -$81.82M -$41.58M -$5.32M -$1.2M
USD/shares -$0.16 -$1.18 -$3.83 -$3.44 -$2.80 -$1.74 -$0.51
USD/shares -$0.16 -$1.18 -$3.83 -$3.44 -$2.80 -$1.74 -$0.51
shares 52.23M 36.11M 34.11M 29.27M 23.86M 10.53M 6.05M
shares 52.23M 36.11M 34.11M 29.27M 23.86M 10.53M 6.05M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 5.48×
EV/EBIT
Peer median 10.68×
P/E (TTM)
Peer median 8.07×

Peer medians compare against the 309 similar-size Biotechnology companies (of 536 listed).

Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 24 filings 24 filers Visit website Investor relations